A study from China published in the Journal of Clinical Oncology has shown that CAR T-cell therapy that targets CD19 and CD22 is effective at treating recurrent or refractory acute lymphoblastic leukemia in children.
2022 ASCO Annual Meeting Research Round Up: New Research in Lung Cancer, Lymphoma, and Childhood Cancers
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in non-small cell lung cancer, non-Hodgkin lymphoma, Ewing sarcoma, and neuroblastoma.
2022 ASCO Annual Meeting Research Round Up: New Research in Head and Neck Cancer, Brain Tumors, and Health Equity
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in head and neck cancer, brain tumors, and health equity.
In this post, several experts describe what Hodgkin lymphoma survivors who received mantle radiation should know about their increased breast cancer risk, including what to know about screening and monitoring for signs of breast cancer.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s research includes a study on a targeted therapy combination for treating low-grade childhood glioma with a BRAF V600 mutation.
Karen Cordova shares what it was like losing her childhood best friend to cancer, including the difficulty that came with understanding her friend’s death as a child and how she honors her friend today as an adult.
People may have concerns about whether living near power lines can increase their risk for cancer. Here, we discuss where this fear comes from and what the research says about power lines and cancer risk.
In this “Your Stories” podcast from Conquer Cancer, the ASCO Foundation, Dr. Mark Applebaum discusses what it’s like to provide care for children with cancer and how research can help kids live more comfortably through the cancer experience.
In this podcast, 3 experts discuss what it means to have the capacity to make decisions during cancer, and what families and caregivers should know if they need to make decisions on behalf of someone else.
In this podcast, Cancer.Net Associate Editors discuss new research from the ASCO20 Virtual Scientific Program and what it means for patients.